Related Experiment Video

Updated: Jul 8, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

[Characteristics of chronic viral hepatitis B in children of various ages]

F I Inoiatova, B A Kadyrov, Sh U Abdumadzhidova

    Likars'Ka Sprava
    |June 21, 2002
    PubMed

    Insights

    Chronic viral hepatitis B (CVHB) in children shows age-related differences in disease progression. Understanding these patterns is crucial for tailoring treatment strategies in pediatric patients.

    Area of Science:

    • Hepatology
    • Pediatric Infectious Diseases
    • Virology

    Context:

    • Chronic viral hepatitis B (CVHB) is a significant health concern in children.
    • Long-term follow-up studies are essential for understanding disease trajectories.
    • Pediatric hepatitis B management requires age-specific considerations.

    Purpose:

    • To investigate age-associated differences in the clinical course of chronic viral hepatitis B in children.
    • To correlate disease manifestations with specific age groups.
    • To inform treatment decisions based on age-related disease patterns.

    Summary:

    • In children aged 1 year, CVHB shows a slow progression with increasing liver size but fewer clinical symptoms.
    • Hepatomegaly and meteorism are common, contributing to increased abdominal mass.
    • Younger children (<3 years) with CVHB often experience a progressive disease course with a generally favorable prognosis.
    • Aged-related increase in wave-like disease patterns may accelerate cirrhosis development and recovery.

    Impact:

    • Highlights the importance of age-specific monitoring and management of pediatric CVHB.
    • Provides insights into predicting disease progression and outcomes in different pediatric age groups.
    • Informs clinical decision-making for optimizing treatment strategies in children with CVHB.

    More Related Videos

    Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

    Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

    Published on: September 7, 2022

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

    Published on: December 15, 2023

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Chickenpox01:20

    Chickenpox

    Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...